Potential fluconazole-induced carbamazepine toxicity

OBJECTIVE: To report a case of carbamazepine toxicity resulting from a drug interaction with fluconazole, and to review the possible mechanisms of thi s interaction. DATA SOURCES: Medical record review. DATA SYNTHESIS: A 33-year-old white man with a history of mental retardatio n and seizures experienced stupor due to carbamazepine toxicity after fluco nazole was initiated. The patient had been taking carbamazepine for several years and maintained stable therapeutic concentrations. He started flucona zole therapy after developing a rash presumably due to candidiasis. After a dmission to the hospital for carbamazepine toxicity, both fluconazole and c arbamazepine were withheld and the patient returned to his normal baseline mental status once the carbamazepine concentration declined to a therapeuti c range. Carbamazepine was restarted and the patient experienced no further adverse events. Carbamazepine is metabolized by the cytochrome P450 3A4 is oenzyme. Fluconazole is renally excreted but has been noted to inhibit CYP3 A4, Fluconazole has also been noted to increase phenytoin concentrations. CONCLUSIONS: Fluconazole may cause carbamazepine toxicity presumably by inh ibiting the cytochrome P450 3A4 isoenzyme.